154 related articles for article (PubMed ID: 28360125)
1. Cellular levels of Grb2 and cytoskeleton stability are correlated in a neurodegenerative scenario.
Majumder P; Roy K; Singh BK; Jana NR; Mukhopadhyay D
Dis Model Mech; 2017 May; 10(5):655-669. PubMed ID: 28360125
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Grb2 SH3 domain with UVRAG in an Alzheimer's disease-like scenario.
Roy K; Chakrabarti O; Mukhopadhyay D
Biochem Cell Biol; 2014 Jun; 92(3):219-25. PubMed ID: 24882360
[TBL] [Abstract][Full Text] [Related]
3. Growth factor receptor-bound protein 2 promotes autophagic removal of amyloid-β protein precursor intracellular domain overload in neuronal cells.
Roy K; Raychaudhuri M; Chakrabarti O; Mukhopadhyay D
J Alzheimers Dis; 2014; 38(4):881-95. PubMed ID: 24100123
[TBL] [Abstract][Full Text] [Related]
4. Grb2-mediated alteration in the trafficking of AbetaPP: insights from Grb2-AICD interaction.
Raychaudhuri M; Mukhopadhyay D
J Alzheimers Dis; 2010; 20(1):275-92. PubMed ID: 20164575
[TBL] [Abstract][Full Text] [Related]
5. A nexus of miR-1271, PAX4 and ALK/RYK influences the cytoskeletal architectures in Alzheimer's Disease and Type 2 Diabetes.
Majumder P; Chanda K; Das D; Singh BK; Chakrabarti P; Jana NR; Mukhopadhyay D
Biochem J; 2021 Sep; 478(17):3297-3317. PubMed ID: 34409981
[TBL] [Abstract][Full Text] [Related]
6. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
7. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
8. The Alzheimer amyloid precursor is associated with the detergent-insoluble cytoskeleton.
Refolo LM; Wittenberg IS; Friedrich VL; Robakis NK
J Neurosci; 1991 Dec; 11(12):3888-97. PubMed ID: 1683901
[TBL] [Abstract][Full Text] [Related]
9. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
[TBL] [Abstract][Full Text] [Related]
10. The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer's disease.
Müller T; Meyer HE; Egensperger R; Marcus K
Prog Neurobiol; 2008 Aug; 85(4):393-406. PubMed ID: 18603345
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
12. Small things matter: Implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer's disease.
Bukhari H; Glotzbach A; Kolbe K; Leonhardt G; Loosse C; Müller T
Prog Neurobiol; 2017 Sep; 156():189-213. PubMed ID: 28587768
[TBL] [Abstract][Full Text] [Related]
13. JNK-interacting protein 1 mediates Alzheimer's-like pathological features in AICD-transgenic mice.
Margevicius DR; Bastian C; Fan Q; Davis RJ; Pimplikar SW
Neurobiol Aging; 2015 Aug; 36(8):2370-9. PubMed ID: 26022769
[TBL] [Abstract][Full Text] [Related]
14. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
15. Brain site-specific gene expression analysis in Alzheimer's disease patients.
Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
[TBL] [Abstract][Full Text] [Related]
16. Functional implications of the conformational switch in AICD peptide upon binding to Grb2-SH2 domain.
Das S; Raychaudhuri M; Sen U; Mukhopadhyay D
J Mol Biol; 2011 Nov; 414(2):217-30. PubMed ID: 22001015
[TBL] [Abstract][Full Text] [Related]
17. RanBP9 at the intersection between cofilin and Aβ pathologies: rescue of neurodegenerative changes by RanBP9 reduction.
Woo JA; Boggess T; Uhlar C; Wang X; Khan H; Cappos G; Joly-Amado A; De Narvaez E; Majid S; Minamide LS; Bamburg JR; Morgan D; Weeber E; Kang DE
Cell Death Dis; 2015 Mar; 6(3):1676. PubMed ID: 25741591
[TBL] [Abstract][Full Text] [Related]
18. Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD).
Müller T; Concannon CG; Ward MW; Walsh CM; Tirniceriu AL; Tribl F; Kögel D; Prehn JH; Egensperger R
Mol Biol Cell; 2007 Jan; 18(1):201-10. PubMed ID: 17093061
[TBL] [Abstract][Full Text] [Related]
19. Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse model.
Liao F; Jiang H; Srivatsan S; Xiao Q; Lefton KB; Yamada K; Mahan TE; Lee JM; Shaw AS; Holtzman DM
Mol Neurodegener; 2015 Mar; 10():12. PubMed ID: 25887956
[TBL] [Abstract][Full Text] [Related]
20. Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.
Boerner JL; Danielsen AJ; Lovejoy CA; Wang Z; Juneja SC; Faupel-Badger JM; Darce JR; Maihle NJ
Oncogene; 2003 Oct; 22(43):6679-89. PubMed ID: 14555981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
